Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-10

Clinical Trial Update: Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II [NA]

View source ↗

Summary

The clinical trial evaluating quetiapine for postpartum depression in women with bipolar disorder type II has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: BC Women's Hospital & Health Centre | Conditions: Postpartum Depression | NA | Status: COMPLETED